Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib (CP-690,550) in Active Rheumatoid Arthritis
NCT00147498Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2005
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of tofacitinib oral solution in rheumatoid arthritis (RA), sponsored by Pfizer. Started Jan 2005; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00147498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147498.